2例药源性发热病人的用药分析  

Use Medicine Analysis of Two Patients with Drug-Induced Hyperthermia

作　　者：李莉[1] 方忠宏[1] 曾宏辉[1] 

机构地区：[1]复旦大学附属金山医院,上海200540

出　　处：《中国药事》2012年第7期776-777,共2页Chinese Pharmaceutical Affairs

摘　　要：目的分析2例药源性发热病人的用药情况,为临床合理用药提供参考。方法依据病人临床表现与用药关系,分别认定为低分子右旋糖酐氨基酸注射液、鹿瓜多肽注射液引起。结果与结论为减少药源性疾病的发生及其危害,应规范手术后用药,尽量避免抗菌药物与中药类注射剂等联合使用。Objective To analyse the medical records of 2 inpatients, and to promote safe and rational use of medicine. Methods Medical records of 2 inpatients. The cases of drugdnduced hyperthermia were confirmed by the relationship between the drug administration and the temperature change. The two cases of drug-induced hyperthermia were dextran 40 and amino acids injection, and cervus and cucumis polypeptide injection. Results and Conclusion We suggest that the principle of use medicine in postoperative patients, in order to prevent and to reduce the drug-induced impairment, and avoid combination of antibacterials and traditional Chinese medicine injections as far as possible.

关 键 词：药源性发热 不良反应 抗菌药物 中药注射剂 低分子右旋糖酐氨基酸 鹿瓜多肽注射液 

分 类 号：R994.11[医药卫生—毒理学] R969.3[医药卫生—药学]